Investor information

Type of business:   Wearable dialysis and hemofiltration equipment and materials:

 
Market area:   Hemodialysis and peritoneal dialysis market, blood filtration market
Worldwide 1.8 million patients with medical costs over 50 billion €/year
Main markets: USA 350.000, Europe 320.000, Japan 300.000 patients
Total costs per patient per year amounts to €55.000, sub-divided into:

  • dialysis costs (machine, consumables, nursing) €25.000
  • drugs €6.000
  • medical care €18.000
  • other €6.000 (e.g. transportation)
 
Market potential:   The total worldwide market estimates:

  • sorption filter units for present dialysis systems: €5 billion
  • blood filtration, wearable artificial kidney: €20 billion
 
USP’s:   Highly efficient and effective sorption materials for removing toxins from blood, blood plasma and dialysate fluids:

  • cost effective replacement of hemodialysis fluid in existing HD
  • improved blood filtration for acute renal failure treatment
  • wearable blood filtration unit: wearable artificial kidney
  • better quality of life of ESRD patients:
  • improved blood purification via sorption filtering
  • improved health condition thanks to continuous treatment
  • increased life expectancy for ESRD patients with 10-15 years
  • higher mobility and employability
  • additional savings in medical care and drugs €10.000/patient/year

End Stage Renal Disease patients in 2008
World wide ESRD patients